181 related articles for article (PubMed ID: 20618287)
21. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
[TBL] [Abstract][Full Text] [Related]
22. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study.
Bos MJ; Schipper CM; Koudstaal PJ; Witteman JC; Hofman A; Breteler MM
Circulation; 2006 Oct; 114(15):1591-8. PubMed ID: 17015791
[TBL] [Abstract][Full Text] [Related]
23. Blood pressure, C-reactive protein, and risk of future cardiovascular events.
Blake GJ; Rifai N; Buring JE; Ridker PM
Circulation; 2003 Dec; 108(24):2993-9. PubMed ID: 14638538
[TBL] [Abstract][Full Text] [Related]
24. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
Joffe HV; Ridker PM; Manson JE; Cook NR; Buring JE; Rexrode KM
Ann Epidemiol; 2006 Feb; 16(2):105-12. PubMed ID: 16216530
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein and electrocardiographic ST-segment depression additively predict mortality: the Strong Heart Study.
Okin PM; Roman MJ; Best LG; Lee ET; Galloway JM; Howard BV; Devereux RB
J Am Coll Cardiol; 2005 Jun; 45(11):1787-93. PubMed ID: 15936607
[TBL] [Abstract][Full Text] [Related]
26. Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years.
van Dis I; Kromhout D; Geleijnse JM; Boer JM; Verschuren WM
Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):729-34. PubMed ID: 19809330
[TBL] [Abstract][Full Text] [Related]
27. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension.
Shankar A; Li J; Nieto FJ; Klein BE; Klein R
Am Heart J; 2007 Sep; 154(3):495-501. PubMed ID: 17719297
[TBL] [Abstract][Full Text] [Related]
28. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
Hamer M; Chida Y; Stamatakis E
Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
[TBL] [Abstract][Full Text] [Related]
29. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
[TBL] [Abstract][Full Text] [Related]
30. The associations between current recommendation for physical activity and cardiovascular risks associated with obesity.
Akbartabartoori M; Lean ME; Hankey CR
Eur J Clin Nutr; 2008 Jan; 62(1):1-9. PubMed ID: 17342166
[TBL] [Abstract][Full Text] [Related]
31. The role of conventional and novel mechanisms in explaining increased risk of cardiovascular events in offspring with positive parental history.
Hamer M; Chida Y; Stamatakis E
J Hypertens; 2009 Oct; 27(10):1966-71. PubMed ID: 19587606
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population.
García-Lorda P; Bulló M; Balanzà R; Salas-Salvadó J
Int J Obes (Lond); 2006 Mar; 30(3):468-74. PubMed ID: 16314875
[TBL] [Abstract][Full Text] [Related]
34. Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations.
Wang Z; Rowley K; Best J; McDermott R; Taylor M; O'Dea K
Metabolism; 2007 May; 56(5):629-35. PubMed ID: 17445537
[TBL] [Abstract][Full Text] [Related]
35. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
Cummings DM; King DE; Mainous AG; Geesey ME
Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):180-5. PubMed ID: 16575270
[TBL] [Abstract][Full Text] [Related]
36. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study.
Straczek C; Ducimetiere P; Barberger-Gateau P; Helmer C; Ritchie K; Jouven X; Carcaillon L; Amouyel P; Tzourio C; Empana JP
J Am Geriatr Soc; 2010 Jan; 58(1):129-35. PubMed ID: 20002508
[TBL] [Abstract][Full Text] [Related]
37. Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study.
Raitakari M; Mansikkaniemi K; Marniemi J; Viikari JS; Raitakari OT
J Intern Med; 2005 Nov; 258(5):428-34. PubMed ID: 16238678
[TBL] [Abstract][Full Text] [Related]
38. White blood cell count and C-reactive protein are independent predictors of mortality in the oldest old.
Willems JM; Trompet S; Blauw GJ; Westendorp RG; de Craen AJ
J Gerontol A Biol Sci Med Sci; 2010 Jul; 65(7):764-8. PubMed ID: 20106963
[TBL] [Abstract][Full Text] [Related]
39. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people?
Wang Z; Hoy WE
Med J Aust; 2005 Jan; 182(2):66-9. PubMed ID: 15651963
[TBL] [Abstract][Full Text] [Related]
40. Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth.
Oliveira AC; Oliveira AM; Almeida MS; Silva AM; Adan L; Ladeia AM
J Pediatr; 2008 Mar; 152(3):337-42. PubMed ID: 18280837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
